Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 22.33 · gapped above the open, then crossed back over prior close. High/low 23.00 at 4:15 am ET, 22.17 at 11:30 am ET.
via TCG Crossover Management, LLC, Frazier Life Sciences Management, L.P., Fcpm III Services B.V. +5 more · 11.68% of VOR, 9.98% of AURA
via TCG Crossover Management, LLC, RA Capital Management, LLC, Frazier Life Sciences Management, L.P. +5 more · 11.68% of VOR, 14.13% of ZLAB
via TCG Crossover Management, LLC, VR Adviser, LLC, RA Capital Management, LLC +1 more · 11.68% of VOR, 11.19% of IPSC
via TCG Crossover Management, LLC, RA Capital Management, LLC, Paradigm Biocapital Advisors LP +5 more · 11.68% of VOR, 9.20% of EDIT
via VR Adviser, LLC, TCG Crossover Management, LLC, Frazier Life Sciences Management, L.P. +6 more · 6.26% of VOR, 6.78% of SVRA
via TCG Crossover Management, LLC, VR Adviser, LLC, Braidwell LP +1 more · 11.68% of VOR, 14.33% of SRZN
Managers holding a meaningful stake in VOR also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
Vor Biopharma Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
102 institutional managers report a position in Vor Biopharma Inc. worth $894.2M between them, filed on form 13F for the quarter ending 2026-06-30. 15 of them hold 80% of it, the largest being TCG Crossover Management, LLC at 11.68%.
77 more managers in the register
15 managers hold 80% of the $894.2M institutional base. The other 87 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
VOR (Vor Biopharma Inc.) has 2 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.